User profiles for Anju Nohria
Anju NohriaBrigham and Women's Hospital Verified email at partners.org Cited by 12133 |
Cardiorenal interactions: insights from the ESCAPE trial
A Nohria, V Hasselblad, A Stebbins, DF Pauly… - Journal of the American …, 2008 - jacc.org
Objectives : We examined the ESCAPE (Evaluation Study of Congestive Heart Failure and
Pulmonary Artery Catheterization Effectiveness) database to understand the impact and …
Pulmonary Artery Catheterization Effectiveness) database to understand the impact and …
Role of nitric oxide in the regulation of digital pulse volume amplitude in humans
A Nohria, M Gerhard-Herman… - Journal of applied …, 2006 - journals.physiology.org
Measurement of the increase in digital pulse volume amplitude (PVA) during reactive hyperemia
relative to baseline (PVA-RH) is being applied widely as a convenient test of nitric oxide …
relative to baseline (PVA-RH) is being applied widely as a convenient test of nitric oxide …
Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure
Objectives : This study was designed to determine the relevance of a proposed classification
for advanced heart failure (HF). Profiles based on clinical assessment of congestion and …
for advanced heart failure (HF). Profiles based on clinical assessment of congestion and …
Myocarditis in patients treated with immune checkpoint inhibitors
… Nohria has received research support from Amgen; and has been a consultant for Takeda
Oncology. Dr. Heinzerling has received consultancy, advisory board, and speaker fees from …
Oncology. Dr. Heinzerling has received consultancy, advisory board, and speaker fees from …
Medical management of advanced heart failure
ContextAdvanced heart failure, defined as persistence of limiting symptoms despite therapy
with agents of proven efficacy, accounts for the majority of morbidity and mortality in heart …
with agents of proven efficacy, accounts for the majority of morbidity and mortality in heart …
Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease
A Nohria, ME Grunert, Y Rikitake, K Noma… - Circulation …, 2006 - Am Heart Assoc
Investigations from basic biology suggest that activation of the Rho/Rho kinase pathway
reduces the bioavailability of nitric oxide (NO) and thereby promotes atherosclerosis and its …
reduces the bioavailability of nitric oxide (NO) and thereby promotes atherosclerosis and its …
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
The discipline of Cardio-Oncology has seen tremendous growth over the past decade. It is
devoted to the cardiovascular (CV) care of the cancer patient, especially to the mitigation and …
devoted to the cardiovascular (CV) care of the cancer patient, especially to the mitigation and …
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
…, GD Demetri, A Giordano, K Kelleher, A Nohria… - JAMA …, 2021 - jamanetwork.com
Importance COVID-19 is a life-threatening illness for many patients. Prior studies have
established hematologic cancers as a risk factor associated with particularly poor outcomes from …
established hematologic cancers as a risk factor associated with particularly poor outcomes from …
Cancer therapy–related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging
…, CE Hamo, D Cardinale, B Ky, A Nohria… - Circulation: Heart …, 2016 - Am Heart Assoc
Advances in cancer therapy have resulted in significant improvement in long-term survival
for many types of cancer but have also resulted in untoward side effects associated with …
for many types of cancer but have also resulted in untoward side effects associated with …
Statins inhibit Rho kinase activity in patients with atherosclerosis
BACKGROUND: In addition to inhibiting cholesterol synthesis, statins (HMG-CoA reductase
inhibitors) decrease the formation of isoprenoid intermediates required for the activation of …
inhibitors) decrease the formation of isoprenoid intermediates required for the activation of …